PTSM: Pharmaceutical Technology Sourcing and Management, Dec 1, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Dec 1, 2010
Sourcing
Delivering Value Through Global Procurement
By Patricia Van Arnum
Richard Spoor, senior vice-president of global procurement at Merck & Co., discusses the company's global procurement strategy and philosophy.
Commercial Considerations in Sourcing: Measuring Procurement Success
By Patricia Van Arnum
Measuring the total cost of ownership in customer/supplier relations is crucial in evaluating the performance of a procurement organization.
Seeking Idealized Design to Collaborative Innovation in Sourcing and Procurement
By Patricia Van Arnum
Developing and implementing true collaboration in customer/supplier relationships. This article is part of a special section on sourcing and corporate social responsibility.
Outsourcing
Considerations in Pharmaceutical Outsourcing in China
By Patricia Van Arnum
Sponsor companies need to consider regional- specific factors in the growing and changing market for contract research when outsourcing to China.
CSR and Sustainability Forum
Cholera Outbreak in Haiti Creates Public Health Crisis
The outbreak of cholera in Haiti is causing a public health crisis that is requiring international efforts to stem the disease.
WHO Report Outlines Successes, Challenges and Strategies for Combating Neglected Tropical Disease
By Patricia Van Arnum
Pharmaceuticals, improvement in healthcare delivery systems, veterinary care, and poverty-alleviation remedies are part of an overall strategy for addressing neglected tropical diseases.
CSR and Sustainability Forum
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Click here